Microbiology Insights
A complete buyer’s guide for choosing EM vendors, media, air samplers, and software in pharma microbiology to ensure compliance and reliability.
Mrudula Kulkarni | Sep 22, 2025
Designing an EM Program – Locations, Frequency & Maps in the Pharmaceutical Microbiology Industry
Mrudula Kulkarni | Sep 22, 2025
USP <1116> – Alert/Action Levels & Trending in Pharmaceutical Cleanrooms
Mrudula Kulkarni | Sep 22, 2025
Other trending pieces on pharma manufacturing you may like to read
Designing “Observation-Proof” Cleanrooms (Post-Annex 1) in the Pharmaceutical Industry
Explore how Annex 1 has transformed cleanroom design with observation-proof layouts ensuring visible, built-in GMP compliance.
by Vaibhavi M.
Inside Regulatory Minds: How The FDA And MHRA Evaluate Contamination Control Strategies (CCS)?
Understand FDA and MHRA expectations for CCS and how pharma facilities can ensure compliance with Annex 1 and GMP guidelines.
by Simantini Singh Deo
Gap-To-Green: A 5-Step CCS Gap-Assessment Playbook
Discover the 5-step Gap-to-Green Playbook for achieving Annex 1 compliance and strong contamination control in pharma facilities.
by Simantini Singh Deo
Visual Inspection & Micro Risk Linkages In the Pharmaceutical Cleanroom Industry
Explore how visual inspection links to microbial risk and strengthens contamination control in modern pharmaceutical cleanrooms.
by Vaibhavi M.
RABS vs Isolators – The CCS ROI Debate
RABS or Isolators? Uncover which barrier delivers better ROI and sterility assurance in aseptic pharma manufacturing.
by Mrudula Kulkarni
